Ged Yasser, Singla Nirmish
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kidney Cancer J. 2024 Mar;22(1):28-32.
The 2024 American Society of Clinical Oncology (GU ASCO 2024) Genitourinary Cancers Symposium brought together leading cancer specialists from around the world to discuss the latest breakthroughs in treating genitourinary cancers, especially kidney cancer. The focus was on immunotherapy and combination treatments, offering promising new options for patients with advanced and high-risk tumors. The symposium also highlighted advancements in patient care, including a new tool to assess quality of life in people with metastatic kidney cancer.
2024年美国临床肿瘤学会（泌尿生殖系统肿瘤研讨会，即GU ASCO 2024）汇聚了来自世界各地的顶尖癌症专家，共同探讨泌尿生殖系统癌症（尤其是肾癌）治疗方面的最新突破。会议重点关注免疫疗法和联合治疗，为晚期和高危肿瘤患者提供了有前景的新选择。研讨会还强调了患者护理方面的进展，包括一种评估转移性肾癌患者生活质量的新工具。
